|
Sign In to gain access to subscriptions and/or personal tools.
|
Pharmacotherapy of Acute Lung Injury and the Acute Respiratory Distress Syndrome
Magda Cepkova, MD
Cardiovascular Research Institute and Department of Medicine, University of California San Francisco, magdac72{at}yahoo.com
Michael A. Matthay, MD
Department of Medicine and Anesthesia, University of California San Francisco
Acute lung injury and the acute respiratory distress syndrome are common syndromes with a high mortality rate that affect both medical and surgical patients. Better understanding of the pathophysiology of acute lung injury and the acute respiratory distress syndrome and advances in supportive care and mechanical ventilation have led to improved clinical outcomes since the syndrome was first described in 1967. Although several promising pharmacological therapies, including surfactant, nitric oxide, glucocorticoids and lysofylline, have been studied in patients with acute lung injury and the acute respiratory distress syndrome, none of these pharmacological treatments reduced mortality. This article provides an overview of pharmacological therapies of acute lung injury and the acute respiratory distress syndrome tested in clinical trials and current recommendations for their use as well as a discussion of potential future pharmacological therapies including ß2-adrenergic agonist therapy, keratinocyte growth factor, and activated protein C.
Key Words: acute lung injury • acute respiratory distress syndrome • pulmonary edema • pharmacologic therapies
Journal of Intensive Care Medicine, Vol. 21, No. 3,
119-143 (2006)
DOI: 10.1177/0885066606287045
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
J.-L. Vincent, Y. Sakr, J. Groeneveld, D. F. Zandstra, E. Hoste, Y. Malledant, K. Lei, and C. L. Sprung
ARDS of Early or Late Onset: Does It Make a Difference?
Chest,
January 1, 2010;
137(1):
81 - 87.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. Zmijewski, E. Lorne, X. Zhao, Y. Tsuruta, Y. Sha, G. Liu, and E. Abraham
Antiinflammatory Effects of Hydrogen Peroxide in Neutrophil Activation and Acute Lung Injury
Am. J. Respir. Crit. Care Med.,
April 15, 2009;
179(8):
694 - 704.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Mayer, A. Kiessling, J. Ott, M. B. Schaefer, M. Hecker, I. Henneke, R. Schulz, A. Gunther, J. Wang, L. Wu, et al.
Acute Lung Injury Is Reduced in fat-1 Mice Endogenously Synthesizing n-3 Fatty Acids
Am. J. Respir. Crit. Care Med.,
March 15, 2009;
179(6):
474 - 483.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M R Looney, C T Esmon, and M A Matthay
Role of coagulation pathways and treatment with activated protein C in hyperoxic lung injury
Thorax,
February 1, 2009;
64(2):
114 - 120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C S Calfee, L B Ware, M D Eisner, P E Parsons, B T Thompson, N Wickersham, M A Matthay, and the NHLBI ARDS Network
Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury
Thorax,
December 1, 2008;
63(12):
1083 - 1089.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. D. Liu, J. Levitt, H. Zhuo, R. H. Kallet, S. Brady, J. Steingrub, M. Tidswell, M. D. Siegel, G. Soto, M. W. Peterson, et al.
Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung Injury
Am. J. Respir. Crit. Care Med.,
September 15, 2008;
178(6):
618 - 623.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ikegami, A. Falcone, and J. A. Whitsett
STAT-3 regulates surfactant phospholipid homeostasis in normal lung and during endotoxin-mediated lung injury
J Appl Physiol,
June 1, 2008;
104(6):
1753 - 1760.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Matthay
Treatment of Acute Lung Injury: Clinical and Experimental Studies
Proceedings of the ATS,
April 15, 2008;
5(3):
297 - 299.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A Matthay and J. Lee
{beta}2 Adrenergic agonist therapy may enhance alveolar epithelial repair in patients with acute lung injury
Thorax,
March 1, 2008;
63(3):
189 - 190.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. D. Liu and M. A. Matthay
Advances in Critical Care for the Nephrologist: Acute Lung Injury/ARDS
Clin. J. Am. Soc. Nephrol.,
March 1, 2008;
3(2):
578 - 586.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Lagan, D. D. Melley, T. W. Evans, and G. J. Quinlan
Pathogenesis of the systemic inflammatory syndrome and acute lung injury: role of iron mobilization and decompartmentalization
Am J Physiol Lung Cell Mol Physiol,
February 1, 2008;
294(2):
L161 - L174.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ikegami, E. A. Scoville, S. Grant, T. Korfhagen, W. Brondyk, R. K. Scheule, and J. A. Whitsett
Surfactant Protein-D and Surfactant Inhibit Endotoxin-Induced Pulmonary Inflammation
Chest,
November 1, 2007;
132(5):
1447 - 1454.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. R. Prows, A. P. Hafertepen, A. V. Winterberg, W. J. Gibbons Jr., C. Liu, and T. G. Nick
Genetic analysis of hyperoxic acute lung injury survival in reciprocal intercross mice
Physiol Genomics,
August 20, 2007;
30(3):
271 - 281.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. Zmijewski, X. Zhao, Z. Xu, and E. Abraham
Exposure to hydrogen peroxide diminishes NF-{kappa}B activation, I{kappa}B-{alpha} degradation, and proteasome activity in neutrophils
Am J Physiol Cell Physiol,
July 1, 2007;
293(1):
C255 - C266.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. N. McLaughlin, M. M. Patterson, and A. B. Malik
Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization
PNAS,
March 27, 2007;
104(13):
5662 - 5667.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. Calfee and M. A. Matthay
Nonventilatory Treatments for Acute Lung Injury and ARDS
Chest,
March 1, 2007;
131(3):
913 - 920.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Steingrub
Adding Up the Zeros
J Intensive Care Med,
May 1, 2006;
21(3):
188 - 190.
[PDF]
|
|
|
|
|
